Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrigin Regulatory News (OGN)

Share Price Information for Origin (OGN)

Share Price is delayed by 15 minutes
Get Live Data
365.00    0.00 (0.00%)
Bid:
360.00
Ask:
370.00
Spread: 10.00 (2.778%)
Market Cap: £392.33m
OGN Live PriceLast checked at - London Stock Exchange

Intraday Origin Share Chart

Directorate Update

1 Oct 2018 16:59

RNS Number : 5966C
Origin Enterprises Plc
01 October 2018
 

 

Directorate Update

1 October 2018

 

Origin Enterprises plc ('Origin' or the 'Company') announces the appointment of Sean Coyle (45) to the Board of the Company with effect from today 1 October 2018, as previously outlined in the regulatory announcements of 7 June 2018 and 26 September 2018. Sean was appointed Chief Financial Officer on 1 September 2018.

 

Full details of his current and past directorships within the last five years are outlined below. None of these entities have any relationship with Origin Enterprises plc.

 

There are no other items requiring disclosure in accordance with Schedule 2(g) of the AIM Rules for Companies or the ESM Rules for Companies. Sean Coyle currently has an interest in 7,000 ordinary shares in Origin.

 

Current Directorships

 

None

 

Past Directorships

Sean Gerard Coyle was a director or partner of the following within the last five years:

 

Steel Eagle Holdings, Inc

Dull Investment Corporation

Sharp Clinical Services Incorporated

Sharp Corporation

Ashfield Healthcare Communications, LLC

Ballina Pharma Inc

Magna Healthcare Inc

Ashfield Healthcare LLC

UDG Healthcare Limited

UDG Healthcare UK (Holdco) Limited

Mantis Surgical Limited

Mediscope Limited

Barclay (Northern Ireland) Limited

Klondyke Enterprises Limited

Mansett Limited

Network Hospital Services Limited

Robert Smith & Co. (Derry) Limited

Vector Scientific Limited

Intraveno (N.I.) Limited

New Splint Limited

Unitech Equipment Limited

TD Packaging Limited

Ashfield Alliance Limited

Ashfield Healthcare (Ireland) Limited

Dublin Drug (Investments) Limited

Dublin Drug Company Limited

Dublin Drug Public Limited Company

Dugdale Trading Limited

Marker (U.D.) Ireland Limited

Oremelt Company Unlimited Company

Pharmexx Ireland (Sales Solutions) Limited

UDG Healthcare Ayrtons (Dublin) Limited

UDG Healthcare Finance Limited

UDG Healthcare Ireland Limited

UDG Healthcare Nordic Limited

UDG Healthcare Packaging Group Limited

UDG Healthcare Property Holdings Limited

United Care Limited

Aquilant Analytical Sciences Limited

Aquilant Endoscopy Limited

Aquilant Limited

Aquilant Medical (ROI) Limited

Aquilant Nederland B.V.

Aquilant Northern Ireland Limited

Aquilant Pharmaceuticals Limited

Aquilant Scientific (ROI) Limited

UDG Healthcare Specialist Product Services Limited

Alchem Plc

Pemberton Marketing Limited

Magir Limited

UDG Healthcare Distributors Limited

The Health Insurance Authority

Marker International BV

Magna Finance BV

UniDrug Distribution Group Limited

 

ENDS

 

 

 

 

 

 

Enquiries:

 

Peter Dunne +353 (0)1 563 4965

Company Secretary

Origin Enterprises plc

 

Davy (Nominated Adviser)

Anthony Farrell + 353 (0)1 614 9993

 

 

About Origin Enterprises plc

Origin Enterprises plc is a focused Agri-Services group providing specialist On-Farm Agronomy Services, Digital Agricultural Services and the supply of crop technologies and inputs. The Group has leading market positions in Ireland, the United Kingdom, Belgium, Brazil, Poland, Romania and Ukraine. Origin is listed on the ESM and AIM markets of the Irish and London Stock Exchanges.

 

ESM ticker symbol: OIZ

AIM ticker symbol: OGN

 

Website: www.originenterprises.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRBUBDGSUGBGIB
Date   Source Headline
10th Jan 20185:11 pmRNSHolding in Company
27th Nov 20175:50 pmRNSHolding in Company
24th Nov 20172:30 pmRNSAnnual General Meeting
24th Nov 20177:00 amRNSTrading Update
3rd Nov 20174:05 pmRNSBlock Listing Six Monthly Return
26th Oct 20173:14 pmRNSPosting of 2017 Annual Report and Notice of AGM
18th Oct 20175:45 pmRNSAnnual Report and Accounts 2017
28th Sep 201712:00 pmRNSDirector/PDMR Shareholding
27th Sep 20177:00 amRNSAppointment of London-based Broker
27th Sep 20177:00 amRNSPreliminary Results Statement 2017
11th Sep 20173:38 pmRNSHolding(s) in Company
8th Sep 20173:26 pmRNSHolding in Company
11th Aug 20174:31 pmRNSHolding in Company
10th Aug 20179:00 amRNSOrigin completes the acquisition of Bunn
28th Jul 201710:00 amRNSCMA update on Origin's agreement to acquire Bunn
14th Jul 20177:06 amRNSCMA decision on Origin's agreement to acquire Bunn
14th Jun 201711:00 amRNSCapital Markets Day
1st Jun 201712:50 pmRNSHolding in Company
31st May 20172:02 pmRNSHolding in Company
30th May 20177:00 amRNSHolding in Company
25th May 20177:00 amRNSTrading Statement
5th May 20177:00 amRNSEnterprise Securities Market Notice
4th May 20177:00 amRNSBlock Listing Application
28th Apr 20174:05 pmRNSHolding in Company
5th Apr 20174:12 pmRNSHolding in Company
10th Mar 201712:59 pmRNSDirector/PDMR Shareholding
9th Mar 20177:01 amRNSInterim Results Statement
9th Mar 20177:00 amRNSAcquisition
7th Mar 20177:00 amRNSAcquisition
24th Feb 201710:14 amRNSHolding in Company
20th Feb 20173:03 pmRNSHolding in Company
19th Jan 20174:38 pmRNSHolding in Company
12th Dec 20169:00 amRNSStrategic Research Partnership
8th Dec 20167:00 amRNSOrganisational Announcement
29th Nov 201611:50 amRNSHolding in Company
25th Nov 20162:00 pmRNSResult of AGM
25th Nov 20167:00 amRNSTrading Update
4th Nov 201612:25 pmRNSHolding in Company
26th Oct 20165:16 pmRNSPosting of 2016 Annual Report and Notice of AGM
19th Oct 20163:20 pmRNSHolding in Company
18th Oct 201612:25 pmRNSAnnual Report and Accounts 2016
28th Sep 20167:00 amRNSPreliminary Results Statement 2016
19th Aug 20169:36 amRNSHolding in Company
11th Aug 20165:15 pmRNSHolding in Company
5th Aug 201612:30 pmRNSHolding in Company
3rd Aug 20161:10 pmRNSHolding in Company
2nd Aug 201610:35 amRNSHolding in Company
2nd Aug 201610:30 amRNSHolding in Company
20th Jul 20164:00 pmRNSHolding in Company
19th Jul 20162:45 pmRNSHolding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.